TheraRadar
← Back
Data updated: Jun 28, 2026

VKT PHARMA

Generics

VKT PHARMA is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.

2019
Since
5
Drugs
-
Trials
1
New Drugs (2yr)

VKT PHARMA's Key Drugs

VKT PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

VKT PHARMA's Therapeutic Areas

VKT PHARMA's approved drugs and pipeline span 2 therapeutic areas, led by Gastroenterology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Gastroenterology 50%
1 drugs
Cardiovascular 50%
1 drugs

VKT PHARMA's Top Competitors

VKT PHARMA's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Takeda, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

VKT PHARMA Pipeline Snapshot

Active clinical trials for VKT PHARMA across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Gastroenterology pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling